Teaching plan

Date	Teacher	Place	Topic	Lecture notes / comments
19.01.2009	Jan Abel Olsen	12.15-14.00, Forskningsveien 2B	Introduction. Overview of the methodologies; CBA vs CEA. Efficiency; markets and market failures. Positive and normative issues.
26.01.2009	Eline Aas	12.15-16.00, Seminarrom 6, Harald Schjelderups hus	Cost concepts and costs in economic evaluation. Average, marginal and Incremental costs
02.02.2009	Eline Aas	12.15-16.00, Seminarrom 6, Harald Schjelderups hus	Private vs social costs. Time costs Production losses.
09.02.2009	Eline Aas	12.15-16.00, Seminarrom 6, Harald Schjelderups hus	Discounting costs and health effects.
16.02.2009	Jan Abel Olsen	12.15-14.00, Seminarrom 4, Harald Schjelderups hus	CBA – valuing benefits/outcomes in money terms. WTP and production gains.
17.02.2009	Jan Abel Olsen	10.15-12.00, Seminarrom 3, Harald Schjelderups hus	On CBA: WTP and production gains	Seminar
23.02.2009	Jan Abel Olsen	12.15-15.00, Seminarrom 6, Harald Schjelderups hus	CEA/CUA – valuing benefits/ outcomes in health terms. QALYs
02.03.2009	Ivar S. Kristiansen	12.15-15.00, Seminarrom 6, Harald Schjelderups hus	Applied CEA. Translating end-points used in clinical trials to CEA/CUA type units.
09.03.2009	Ivar S. Kristiansen	12.15-15.00, Seminarrom 6, Harald Schjelderups hus	Modelling. From risk-reductions to increased life-time and/or improved health status Modelling II: computer exercise.
16.03.2009	Ivar S. Kristiansen	12.15-15.00, Seminarrom 6, Harald Schjelderups hus	ICER, Sensitivity analyses, deterministic and probabilistic.
23.03.2009	Jan Abel Olsen	12.15-15.00, Seminarrom 6, Harald Schjelderups hus	Efficiency vs equity; fair distributions, priority setting The application of CEA and CBA in health policy; guidelines.
14.04.2009	Ivar S. Kristiansen	08.00-12.00, Seminarrom 1, Harald Schjeldrups Hus	Ekstraforelesning
12.05.2009		09.00-13.00	EXAM